Edwards Lifesciences
1,213 hedge funds and large institutions have $37.5B invested in Edwards Lifesciences in 2024 Q4 according to their latest regulatory filings, with 188 funds opening new positions, 348 increasing their positions, 498 reducing their positions, and 140 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
6.35% more ownership
Funds ownership: 78.76% → 85.11% (+6.4%)
3% more funds holding
Funds holding: 1,183 → 1,213 (+30)
30% less repeat investments, than reductions
Existing positions increased: 348 | Existing positions reduced: 498
Holders
1,213
Holding in Top 10
10
Calls
$586M
Puts
$264M
Top Buyers
| 1 | +$556M | |
| 2 | +$550M | |
| 3 | +$484M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$473M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$260M |
Top Sellers
| 1 | -$394M | |
| 2 | -$366M | |
| 3 | -$171M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
-$140M |
| 5 |
CIM
CCLA Investment Management
London,
United Kingdom
|
-$133M |